Atumelnant — Drug Intelligence | 3 EU Trials

Filter these 3 trials by condition, phase, country and more.

3 Registered trials

3 Recruiting

0 Completed trials

1 Sponsors

8 Countries

Phase III

Phase II/III

Phase II

Phase III: 1 Phase II/III: 1 Phase II: 1

Sponsors using this IMP

3 total

A Study in Pediatric Participants with Congenital Adrenal Hyperplasia Recruiting

2024-519578-38-00 Phase II/III 6 countries Crinetics Pharmaceuticals Inc.
A Study to Evaluate Atumelnant in Adults with Congenital Adrenal Hyperplasia Recruiting

2024-519579-24-00 Phase III 7 countries Crinetics Pharmaceuticals Inc.
A study to learn about the safety and effectiveness of CRN04894 on participants Recruiting

2024-514846-35-00 Phase II 2 countries Crinetics Pharmaceuticals Inc.

Showing 1–3 of 3 trials